Stock Plans (Tables)

9 Months Ended

Feb. 22, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Compensation Expense Related to Stock-Based Payments

Compensation expense related to stock-based payments recognized in the Consolidated Statements of Earnings was as follows:

	Quarter Ended		Nine-Month Period Ended
In Millions	Feb. 22, 2026	Feb. 23, 2025	Feb. 22, 2026	Feb. 23, 2025
Compensation expense related to stock-based payments	$26.3	$20.5	$65.6	$67.1

Windfall (shortfall) tax benefits from stock-based payments in income tax expense in our Consolidated Statements of Earnings were as

follows:

	Quarter Ended		Nine-Month Period Ended
In Millions	Feb. 22, 2026	Feb. 23, 2025	Feb. 22, 2026	Feb. 23, 2025
Windfall (shortfall) tax benefits from   stock-based payments	$0.4	$1.1	$(1.2)	$5.9

Schedule of Net Cash Proceeds and Intrinsic Value of Options Exercised

Net cash proceeds from the exercise of stock options less shares used for withholding taxes and the intrinsic value of options exercised

were as follows:

	Nine-Month Period Ended
In Millions	Feb. 22, 2026	Feb. 23, 2025
Net cash proceeds	$0.4	$38.4
Intrinsic value of options exercised	$—	$11.0

Schedule of Estimated Fair Value of Stock Options Granted and Assumptions Used for Black-Scholes Option-Pricing Model

The estimated fair values of stock options granted and the assumptions used for the Black-Scholes option-pricing model were as

follows:

	Nine-Month Period Ended
	Feb. 22, 2026		Feb. 23, 2025
Estimated fair values of stock options granted	$9.45		$13.26
Assumptions:
Risk-free interest rate	4.2	%	4.5	%
Expected term	8.0 years		8.5 years
Expected volatility	22.3	%	21.6	%
Dividend yield	4.7	%	3.8	%

Schedule of Grant Date Fair Value of Restricted Stock Unit Awards Activity

The total grant date fair value of restricted stock unit awards that vested during the period was as follows:

	Nine-Month Period Ended
In Millions	Feb. 22, 2026	Feb. 23, 2025
Total grant date fair value	$109.2	$111.3